PrEP My Way: a patient-friendly plan to help young Kenyan women stick with PrEP
Official title: PrEP My Way: A hybrid type 1 clinical effectiveness-implementation trial to promote PrEP persistence among young Kenyan women
Funded at Massachusetts General Hospital · NIH-11534545 · Data updated 2026-11-12
A patient-centered trial tests a new PrEP delivery approach that supports young women in staying on PrEP and protecting themselves and their babies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | July 23, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $10,967 |
| NIH project number | 3R01MH138255-03S2 |
| Project ID | NIH-11534545 on NIH RePORTER |
Who could benefit from this research
✓Could help
Young women at risk of HIV who are considering or currently using PrEP and are able to engage with peer-supported delivery and self-testing options.
✕Less likely to help
Individuals who are not interested in peer-supported delivery, self-testing, or multi-formulation PrEP may not benefit.
What this research studies
This study aims to help young women stay on PrEP by offering clinic initiation, peer-delivered self-testing kits, PrEP refills, STI self-swab kits, pregnancy testing, and family planning options, with choices about PrEP formulations. It uses Social Cognitive Theory to guide how people choose and adhere to PrEP and how support is provided over time. The project builds on pilot work that showed the approach is feasible and accepted, and it seeks to translate that into higher PrEP use and PMTCT benefits in real-world settings.
Why it matters
Potential benefit: If successful, the approach could increase PrEP persistence among young women, reducing HIV infection risk and improving PMTCT outcomes.
How similar studies have gone: Pilot work showed feasibility and acceptability, suggesting this approach could generalize to broader settings.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Haberer, Jessica Elizabeth — Massachusetts General Hospital
- Study coordinator: Haberer, Jessica Elizabeth
Related research
Other NIH-funded projects on the same topics.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
Harnessing male peer networks to boost HIV testing and PrEP use
A large clinical trial in South Africa tests whether giving HIV self-test kits through male peer networks, with phone support, increases PrEP uptake among men.
-
Harnessing men's peer networks to boost HIV self-testing and PrEP use
A large project in South Africa tests whether giving HIV self-test kits through men’s social networks, with phone support, can lead to more men starting PrEP and using HIV testing.
-
Participatory system dynamics to improve PrEP access in the Bronx
A community-driven project in the Bronx will use system dynamics to identify practical ways to help people at risk for HIV start and stay on PrEP.
-
TB PrEP: Bringing HIV prevention to households affected by TB in Uganda
Aims to help people in households with TB in Uganda access HIV PrEP as part of a combined prevention approach.
-
CARES: A practical program to help adolescent girls and young women use PrEP in Africa
A program called CARES helps young women in South Africa and Zimbabwe use different PrEP options better, with counseling, reminders, and options for support.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.